Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Parker-Hannifin
PH
|
+$328M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Union Pacific
UNP
|
+$267M |
| 4 |
McDonald's
MCD
|
+$267M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$592M |
| 2 |
Apple
AAPL
|
+$536M |
| 3 |
Amgen
AMGN
|
+$492M |
| 4 |
General Dynamics
GD
|
+$395M |
| 5 |
CSX Corp
CSX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.99% |
| 3 | Financials | 13.93% |
| 4 | Industrials | 13.2% |
| 5 | Consumer Discretionary | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMX
51
DELISTED
Terminix Global Holdings, Inc.
TMX
| $698M | 0.41% |
20,495,716
-404,579
| -2% | -$14.1M |
|
|
AGN
52
DELISTED
Allergan plc
AGN
| $692M | 0.41% |
4,110,356
-1,184,207
| -22% | -$199M |
|
53
Air Products & Chemicals
APD
$66.3B
| $691M | 0.41% |
4,347,503
+1,247,308
| +40% | +$206M |
|
54
Estee Lauder
EL
$29B
| $684M | 0.4% |
4,570,930
+248,444
| +6% | +$34.4M |
|
55
Coca-Cola
KO
$354B
| $679M | 0.4% |
15,623,187
+1,104,426
| +8% | +$49.6M |
|
56
Progressive
PGR
$124B
| $669M | 0.39% |
10,973,560
+936,852
| +9% | +$53.5M |
|
57
Amphenol
APH
$188B
| $656M | 0.39% |
30,461,720
-7,447,680
| -20% | -$168M |
|
58
Aon
AON
$77.3B
| $633M | 0.37% |
4,512,077
-51,832
| -1% | -$7.26M |
|
59
WEX
WEX
$6.11B
| $628M | 0.37% |
4,009,921
-27,850
| -0.7% | -$4.19M |
|
60
Aptiv
APTV
$12B
| $623M | 0.37% |
7,327,590
+577,831
| +9% | +$52.4M |
|
61
Neurocrine Biosciences
NBIX
$17.7B
| $619M | 0.36% |
7,463,994
+1,691,883
| +29% | +$143M |
|
|
AET
62
DELISTED
Aetna Inc
AET
| $618M | 0.36% |
3,655,888
-1,059,419
| -22% | -$190M |
|
63
LPL Financial
LPLA
$26.3B
| $601M | 0.35% |
9,838,347
+226,733
| +2% | +$14.1M |
|
64
NVIDIA
NVDA
$5.01T
| $597M | 0.35% |
103,134,400
+19,307,200
| +23% | +$113M |
|
|
NATI
65
DELISTED
National Instruments Corp
NATI
| $570M | 0.34% |
11,275,578
-25,652
| -0.2% | -$1.25M |
|
66
US Bancorp
USB
$99.6B
| $566M | 0.33% |
11,199,951
-366,129
| -3% | -$20M |
|
67
Nektar Therapeutics
NKTR
$2.39B
| $561M | 0.33% |
352,187
+98,499
| +39% | +$127M |
|
68
Sherwin-Williams
SHW
$78.3B
| $561M | 0.33% |
4,293,165
+382,662
| +10% | +$52.2M |
|
69
LyondellBasell Industries
LYB
$19.5B
| $560M | 0.33% |
5,296,481
+108,466
| +2% | +$12.1M |
|
70
Flex
FLEX
$43.4B
| $558M | 0.33% |
45,356,811
-369,467
| -0.8% | -$5.04M |
|
71
Amdocs
DOX
$5.53B
| $558M | 0.33% |
8,359,018
+813,361
| +11% | +$54.7M |
|
72
Gartner
IT
$9.41B
| $552M | 0.33% |
4,695,620
-223,024
| -5% | -$27.9M |
|
73
Illinois Tool Works
ITW
$81.4B
| $551M | 0.32% |
3,516,775
+38,964
| +1% | +$6.47M |
|
74
Regeneron Pharmaceuticals
REGN
$68.8B
| $551M | 0.32% |
1,599,434
-74,406
| -4% | -$25.9M |
|
75
Cimpress
CMPR
$2.37B
| $549M | 0.32% |
3,551,372
-406,334
| -10% | -$60.5M |
|
Similar funds
Janus Henderson Group's Q1 2018 Portfolio in Review
As of Q1 2018, Janus Henderson Group held 1,432 positions worth $170B, up 3.2% from $165B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Janus Henderson Group's Q1 2018 filing shows 129 new, 552 increased, 608 reduced and 77 closed positions. Its largest new stake was Toronto Dominion Bank: 2,798,450 shares worth $159M. The largest sale was Medtronic, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q1 2018 buy was Toronto Dominion Bank: 2,798,450 shares worth $159M.
- Janus Henderson Group added most to Parker-Hannifin in Q1 2018, an estimated $328M increase.
- Janus Henderson Group's biggest Q1 2018 reduction was Apple, cutting an estimated $536M.
- Janus Henderson Group fully exited Medtronic in Q1 2018, selling an estimated $592M.
- Janus Henderson Group's ten largest holdings make up 15% of its $170B portfolio in Q1 2018.
- Janus Henderson Group opened 129 new positions and closed 77 in Q1 2018.
- Janus Henderson Group's portfolio value rose 3.2% quarter-over-quarter to $170B.
Based on Janus Henderson Group's 13F filing for Q1 2018, filed 14 May 2018.